Bioinformatics AdvancesGenomicsPeer-reviewed journal article
Benchmarking of variant pathogenicity prediction methods using a population genetics approach
Mikhail GudkoviD, Loïc Thibaut, Steven MongeriD, Debjani DasiD, David Scott WinlawiD, Sally L. DunwoodieiD, Eleni GiannoulatouiD, Congenital Heart Disease Synergy Study Group, Natasha NassariD, Edwin Philip KirkiD, Gavin ChapmaniD, Gillian M. BlueiD, Gary F. SholleriD, Samantha J. LainiD
Abstract
MotivationVariant pathogenicity predictors are essential for identifying new associations between genetic variants and rare diseases. However, despite the availability of numerous predictors, there is no clear consensus on which methods provide the most reliable results. The common practice of training, testing, and benchmarking these predictors using known variant sets from disease or mutagenesis studies raises concerns about ascertainment bias and data circularity. ResultsWe benchmarked commonly used pathogenicity predictors using an orthogonal approach that does not rely on predefined "ground truth" datasets. By leveraging population-level genomic data from gnomAD and the Context-Adjusted Proportion of Singletons (CAPS) metric, we identified CADD and REVEL as the best-performing predictors for distinguishing extremely deleterious variants from moderately deleterious ones. REVEL demonstrated superior calibration. Additionally, we show that CAPS can serve as a meta-analysis tool for interpreting variant annotations and highlight biases in ClinVar-based predictor training. Availability and ImplementationCAPS analysis and benchmarking results are available at https://github.com/mgudVCCRI/PopGenVariantFiltering Contacte.giannoulatou@victorchang.edu.au
- Citations
- 3
- FWCI
- 0.80
- Field percentile
- top 28%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Assessing performance of pathogenicity predictors using clinically-relevant variant datasets
Adam C. Gunning, Verity Fryer, … Caroline Fiona Wright·Journal of Medical GeneticsPeer-reviewed·Aug 25, 2020
- Critical assessment of missense variant effect predictors on disease-relevant variant data
Ruchir Rastogi, Ryan Chung, … Nilah M. Ioannidis·Human GeneticsPeer-reviewed·Mar 1, 2025
- How good are pathogenicity predictors in detecting benign variants?
Abhishek Niroula, Mauno Vihinen·PLoS Computational BiologyPeer-reviewed·Feb 11, 2019
- Ancestry-specific performance of variant effect predictors in clinical variant classification
Rachel A. Hoffing, Daniel Zeiberg, … Predrag Radivojac A·bioRxiv·Feb 17, 2026
- varCADD: large sets of standing genetic variation enable genome-wide pathogenicity prediction
Lusiné Nazaretyan, Philipp Rentzsch, Martin Kircher·Genome MedicinePeer-reviewed·Aug 4, 2025
- REVEL is better at predicting pathogenicity of loss-of-function than gain-of-function variants
Jasmin J. Hopkins, Matthew Neil Wakeling, … Thomas William Laver·Human MutationPeer-reviewed·Dec 4, 2023